[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Zheng et al., 2010 - Google Patents

Cyclic tripeptides from the halotolerant fungus Aspergillus sclerotiorum PT06-1

Zheng et al., 2010

Document ID
1454286713271127012
Author
Zheng J
Xu Z
Wang Y
Hong K
Liu P
Zhu W
Publication year
Publication venue
Journal of natural products

External Links

Snippet

Eleven new aspochracin-type cyclic tripeptides, sclerotiotides A− K (1− 11), together with three known compounds, JBIR-15 (12), aspochracin (13), and penicillic acid, were isolated from the ethyl acetate extract of the fermentation broth of the halotolerant Aspergillus …
Continue reading at pubs.acs.org (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography

Similar Documents

Publication Publication Date Title
Zheng et al. Cyclic tripeptides from the halotolerant fungus Aspergillus sclerotiorum PT06-1
Chen et al. Cyclic heptapeptides, cordyheptapeptides C–E, from the marine-derived fungus Acremonium persicinum SCSIO 115 and their cytotoxic activities
Wu et al. Isolation and structural elucidation of proline-containing cyclopentapeptides from an endolichenic Xylaria sp.
Shin et al. Aeruginosins 205A and-B, serine protease inhibitory glycopeptides from the cyanobacterium Oscillatoria agardhii (NIES-205)
Plaza et al. Celebesides A− C and theopapuamides B− D, depsipeptides from an Indonesian sponge that inhibit HIV-1 entry
Zheng et al. Novel cyclic hexapeptides from marine-derived fungus, Aspergillus sclerotiorum PT06-1
Huang et al. Cyclic peptides from an endophytic fungus obtained from a mangrove leaf (Kandelia candel)
Namikoshi et al. Seven new microcystins possessing two L-glutamic acid units, isolated from Anabaena sp. strain 186
Langenfeld et al. Insecticidal cyclodepsipeptides from Beauveria felina
Boot et al. Highly N-methylated linear peptides produced by an atypical sponge-derived Acremonium sp.
Vongvanich et al. Hirsutellide a, a new antimycobacterial cyclohexadepsipeptide from the entomopathogenic fungus hirsutella k obayasii
Ortiz-Lopez et al. Cyclic colisporifungin and linear cavinafungins, antifungal lipopeptides isolated from Colispora cavincola
Sone et al. Dolastatin H and isodolastatin H, potent cytotoxic peptides from the sea hare Dolabella auricularia: Isolation, stereostructures, and synthesis
Yu et al. Cytotoxic microcolin lipopeptides from the marine cyanobacterium Moorea producens
Lang et al. Bioactivity profiling using HPLC/microtiter-plate analysis: application to a New Zealand marine alga-derived fungus, Gliocladium sp.
Williams et al. Ferintoic acids A and B, new cyclic hexapeptides from the freshwater cyanobacterium Microcystis aeruginosa
Rivera-Chávez et al. Biosynthesis of fluorinated peptaibols using a site-directed building block incorporation approach
Fernández et al. Onchidin B: a new cyclodepsipeptide from the mollusc Onchidium sp.
Amagata et al. A chemical study of cyclic depsipeptides produced by a sponge-derived fungus
Stewart et al. Metabolomics-guided discovery of microginin peptides from cultures of the cyanobacterium Microcystis aeruginosa
Mitova et al. Evolving trends in the dereplication of natural product extracts. 2. The isolation of chrysaibol, an antibiotic peptaibol from a New Zealand sample of the mycoparasitic fungus Sepedonium chrysospermum
Liu et al. Trichodestruxins A–D: cytotoxic cyclodepsipeptides from the endophytic fungus Trichoderma harzianum
Pettit et al. Antineoplastic agents. 570. Isolation and structure elucidation of bacillistatins 1 and 2 from a marine Bacillus silvestris
Iwasaki et al. Kohamamides A, B, and C, cyclic depsipeptides from an Okeania sp. marine cyanobacterium
Jang et al. Octaminomycins A and B, cyclic octadepsipeptides active against Plasmodium falciparum